Researchers at Freedom Meditech are developing devices that can non-invasively scan the eye to monitor glucose levels in people with diabetes.
The devices are based optical polarimetry, a technique that measures the concentration of glucose in the aqueous humour, one of the fluids in the eye.
The company has successfully completed a study involving rabbit models, in which the optical polarimetry technique was used to non-invasively measure glucose levels.
Freedom Meditech chairman and CEO Craig Misrach says the company is pleased with the promising results of the study and is planning to move the research to the next phase of human clinical studies.
"We believe that our proprietary technology could someday become a standard of care for quick and convenient glucose monitoring for people with diabetes," Misrach states.
Latest from Today's Medical Developments
- NextDent 300 MultiJet printer delivers a “Coming of Age for Digital Dentistry” at Evolution Dental Solutions
- Get recognized for bringing manufacturing back to North America
- Adaptive Coolant Flow improves energy efficiency
- VOLTAS opens coworking space for medical device manufacturers
- MEMS accelerometer for medical implants, wearables
- The compact, complex capabilities of photochemical etching
- Moticont introduces compact, linear voice coil motor
- Manufacturing technology orders reach record high in December 2025